PROCEPT BioRobotics (PRCT) Gross Margin (2020 - 2026)
PROCEPT BioRobotics' (PRCT) quarterly Gross Margin came in at 66.01% in Q2 2026, up 66.0% year-over-year from 39.77% in Q2 2025, and up 1.72% quarter-over-quarter from 64.89% in Q1 2026.
Powered by 
Analysis
PROCEPT BioRobotics (PRCT) Gross Margin (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Gross Margin for 7 consecutive years, with 66.01% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin rose 66.0% year-over-year to 66.01% in Q2 2026; TTM through Jun 2026 was 64.22%, a 3.0% increase from a year earlier, with the FY2025 full-year figure at 63.7%, up 263.0% from the prior year.
- Gross Margin was 66.01% for Q2 2026 at PROCEPT BioRobotics, up from 64.89% in the prior quarter.
- Over five years, Gross Margin peaked at 66.01% in Q2 2026 and troughed at 44.9% in Q4 2022.
- A 5-year average of 57.64% and a median of 57.61% in 2024 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin jumped 1523 bps in 2024 and tumbled 337 bps in 2025, its largest moves.
- Over 5 years, Gross Margin stood at 44.9% in 2022, then gained by 9 bps to 48.77% in 2023, then jumped by 31 bps to 64.0% in 2024, then slipped by 5 bps to 60.63% in 2025, then increased by 9 bps to 66.01% in 2026.
- The last three Gross Margin figures came in at 66.01% (Q2 2026), 64.89% (Q1 2026), and 60.63% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 45.84% |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn | 66.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.01% |
| Mar 31, 2026 | 64.89% |
| Dec 31, 2025 | 60.63% |
| Sep 30, 2025 | 64.81% |
| Jun 30, 2025 | 65.35% |
| Mar 31, 2025 | 63.85% |
| Dec 31, 2024 | 64.00% |
| Sep 30, 2024 | 63.24% |
| Jun 30, 2024 | 59.01% |
| Mar 31, 2024 | 56.21% |
| Dec 31, 2023 | 48.77% |
| Sep 30, 2023 | 53.77% |
| Jun 30, 2023 | 55.67% |
| Mar 31, 2023 | 51.18% |
| Dec 31, 2022 | 44.90% |
| Sep 30, 2022 | 50.28% |
| Jun 30, 2022 | 50.84% |
| Mar 31, 2022 | 54.18% |
| Dec 31, 2021 | 44.55% |
| Sep 30, 2021 | 48.92% |